Table 3.

Univariate analysis for the risk of graft rejection


Variable

No. patients

No. events (%)

Fisher exact test P

Cumulative incidence of rejection, % (95% CI)

P
Sex    .46    .43  
   Female   31   2 (6)    8 (2-29)   
   Male   41   5 (12)    18 (6-35)   
Sex mismatch in GvH direction, donor→recipient    NS    NS  
   Female→male   19   2 (11)    13 (3-47)   
   Other combinations   53   5 (9)    12 (5-27)   
Sex mismatch in HvG direction, donor→recipient    NS    NS  
   Male→female   18   1 (6)    8 (1-51)   
   Other combinations   54   6 (11)    13 (3-47)   
Patient age at HSCT    NS    NS  
   Younger than 15 y   36   4 (11)    14 (5-35)   
   15 y or older   36   3 (8)    9 (3-26)   
Donor age    .46    .45  
   Younger than 35 y   31   2 (6)    7 (2-25)   
   35 y or older   41   5 (12)    15 (7-35)   
Pesaro classification    NS*   NS  
   Class 1   21   3 (14)    18 (6-51)   
   Class 2   20   1 (5)    10 (3-37)   
   Class 3   31   2 (6)    7 (2-25)   
HCMV serology, donor→recipient    .50*   NS  
   Negative→negative   7   1 (14)    17 (3-100)   
   Negative→positive   16   3 (19)    24 (9-65)   
   Positive→negative   14   1 (7)    7 (1-47)   
   Positive→positive   35   2 (6)    6 (2-23)   
HCMV serology combination, donor→recipient    NS    NS  
   Negative→negative   7   1 (14)    17 (3-100)   
   Others   65   6 (9)    11 (5-24)   
Conditioning regimen    .14*   .14  
   BU + CY   18   3 (17)    17 (6-48)   
   BU + TT + CY   36   1 (3)    3 (0-20)   
   BU + TT + FLU   18   3 (17)    23 (8-63)   
Use of ATG    .36    .32  
   No   54   4 (7)    8 (3-19)   
   Yes   18   3 (17)    23 (8-63)   
Cell dose infused, × 108/kg    NS    NS  
   Less than 5   44   4 (9)    9 (4-24)   
   5 or greater   28   3 (11)    14 (5-40)   
HLA-DPB1 mismatch:    .08*   .048  
   Matched + permissive   45   2 (4)    7 (2-26)   
   Nonpermissive mismatch in GvH direction   10   1 (10)    10 (2-64)   
   Nonpermissive mismatch in HvG direction
 
17
 
4 (24)
 

 
26 (11-60)
 

 

Variable

No. patients

No. events (%)

Fisher exact test P

Cumulative incidence of rejection, % (95% CI)

P
Sex    .46    .43  
   Female   31   2 (6)    8 (2-29)   
   Male   41   5 (12)    18 (6-35)   
Sex mismatch in GvH direction, donor→recipient    NS    NS  
   Female→male   19   2 (11)    13 (3-47)   
   Other combinations   53   5 (9)    12 (5-27)   
Sex mismatch in HvG direction, donor→recipient    NS    NS  
   Male→female   18   1 (6)    8 (1-51)   
   Other combinations   54   6 (11)    13 (3-47)   
Patient age at HSCT    NS    NS  
   Younger than 15 y   36   4 (11)    14 (5-35)   
   15 y or older   36   3 (8)    9 (3-26)   
Donor age    .46    .45  
   Younger than 35 y   31   2 (6)    7 (2-25)   
   35 y or older   41   5 (12)    15 (7-35)   
Pesaro classification    NS*   NS  
   Class 1   21   3 (14)    18 (6-51)   
   Class 2   20   1 (5)    10 (3-37)   
   Class 3   31   2 (6)    7 (2-25)   
HCMV serology, donor→recipient    .50*   NS  
   Negative→negative   7   1 (14)    17 (3-100)   
   Negative→positive   16   3 (19)    24 (9-65)   
   Positive→negative   14   1 (7)    7 (1-47)   
   Positive→positive   35   2 (6)    6 (2-23)   
HCMV serology combination, donor→recipient    NS    NS  
   Negative→negative   7   1 (14)    17 (3-100)   
   Others   65   6 (9)    11 (5-24)   
Conditioning regimen    .14*   .14  
   BU + CY   18   3 (17)    17 (6-48)   
   BU + TT + CY   36   1 (3)    3 (0-20)   
   BU + TT + FLU   18   3 (17)    23 (8-63)   
Use of ATG    .36    .32  
   No   54   4 (7)    8 (3-19)   
   Yes   18   3 (17)    23 (8-63)   
Cell dose infused, × 108/kg    NS    NS  
   Less than 5   44   4 (9)    9 (4-24)   
   5 or greater   28   3 (11)    14 (5-40)   
HLA-DPB1 mismatch:    .08*   .048  
   Matched + permissive   45   2 (4)    7 (2-26)   
   Nonpermissive mismatch in GvH direction   10   1 (10)    10 (2-64)   
   Nonpermissive mismatch in HvG direction
 
17
 
4 (24)
 

 
26 (11-60)
 

 
*

Chi-squared P

or Create an Account

Close Modal
Close Modal